Costo efectividad de la vacunación contra influenza en menores de 2 años y mayores de 65 años en Colombia

October 5, 2017 | Autor: Alexandra Mendoza | Categoría: Economics, Colombia, Cancer, Australia, Quality of life, Risk, Forecasting, Argentina, Treatment Outcome, Decision Analysis, Health Policy, Pharmacoeconomics, Adolescent, Prevention, Israel, Biological Sciences, Decision Trees, Humans, Child, Age, Pneumonia, Young Adult, Infant, Vaccine, Cost effectiveness, Life Expectancy, Incidence, Vaccination, Discount Rate, Risk factors, Newborn Infant, Aged, Middle Aged, Quality adjusted life years, Adult, Economic Models, Cost Benefit Analysis, Retrospective Studies, Age Factors, Economic evaluation, Influenza Vaccine, Risk Factors, Vaccine Effectiveness, Older Adult, Cost of Illness, Health Care Costs, Age Groups, Nino, Immunization Programs, Child preschool, Risk, Forecasting, Argentina, Treatment Outcome, Decision Analysis, Health Policy, Pharmacoeconomics, Adolescent, Prevention, Israel, Biological Sciences, Decision Trees, Humans, Child, Age, Pneumonia, Young Adult, Infant, Vaccine, Cost effectiveness, Life Expectancy, Incidence, Vaccination, Discount Rate, Risk factors, Newborn Infant, Aged, Middle Aged, Quality adjusted life years, Adult, Economic Models, Cost Benefit Analysis, Retrospective Studies, Age Factors, Economic evaluation, Influenza Vaccine, Risk Factors, Vaccine Effectiveness, Older Adult, Cost of Illness, Health Care Costs, Age Groups, Nino, Immunization Programs, Child preschool